The Editor,

Sir,

Treating adult patients with relapsed ALL is still difficult. Only 20 % to 30% of those patients acquired complete remission (CR). Those patients are always of short duration unless an allogeneic hematopoietic stem cell transplant (allo-HSCT) is feasible.